Literature DB >> 3538739

Primary adrenocortical micronodular adenomatosis causing Cushing's syndrome. Effects of ketoconazole on steroid production and in vitro performance of adrenal cells.

W Oelkers, V Bähr, J Hensen, H Pickartz.   

Abstract

Mild Cushing's syndrome was diagnosed in a 35 year old woman. Elevated plasma and urinary cortisol levels were unsuppressible with up to 32 mg dexamethasone per day. Aldosterone, 18-OH-corticosterone and testosterone in plasma were normal and dehydro-epiandrosterone-sulphate was low. No adrenal tumour was found by CT or adrenal venography, and bilateral cortisol secretion was demonstrated by steroid measurements in adrenal venous blood. A circadian rhythm of plasma cortisol was absent. Plasma ACTH was suppressed, even after injection of CRH, during insulin-induced hypoglycaemia and after metyrapone administration, which led to a large fall in plasma cortisol but to a subnormal rise of plasma 11-deoxy-cortisol. The clinical diagnosis of primary micronodular adenomatosis of the adrenal gland was histologically confirmed, when the patient finally underwent bilateral adrenalectomy. In vitro, the adrenal cells did not produce more cortisol and aldosterone than adrenal cells from cadaver kidney donors. In vivo and in vitro, cortisol was slightly less than normally responsive to ACTH. Intermittent treatment of the patient with 800 mg/day of ketoconazole led to a rapid fall of cortisol secretion and clinical signs of adrenocortical insufficiency. Treatment for 7 weeks with 200-400 mg ketoconazole per day reduced plasma and urinary cortisol less dramatically into the normal range. This case unequivocally documents autonomous dysfunction of the adrenal cortex in this rare form of Cushing's syndrome and the efficacy of ketoconazole in the treatment of ACTH-independent hypercortisolism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3538739     DOI: 10.1530/acta.0.1130370

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  8 in total

1.  Primary pigmented micronodular disease of the adrenals.

Authors:  P Limone; M Maccario; R Vigliani; G Isaia; F Massara; G M Molinatti
Journal:  J Endocrinol Invest       Date:  1990-02       Impact factor: 4.256

2.  Preoperative ketoconazole therapy for adrenocortical carcinoma.

Authors:  L J Sinnaeve; G P Becks
Journal:  CMAJ       Date:  1989-07-15       Impact factor: 8.262

Review 3.  Steroid biosynthesis inhibitors in Cushing's syndrome.

Authors:  D Engelhardt
Journal:  Clin Investig       Date:  1994-07

Review 4.  PRKAR1A mutations in primary pigmented nodular adrenocortical disease.

Authors:  Laure Cazabat; Bruno Ragazzon; Lionel Groussin; Jérôme Bertherat
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

5.  Different inhibitory effect of etomidate and ketoconazole on the human adrenal steroid biosynthesis.

Authors:  M M Weber; J Lang; F Abedinpour; K Zeilberger; B Adelmann; D Engelhardt
Journal:  Clin Investig       Date:  1993-11

6.  Efficacy of dexamethasone suppression test during the diagnosis of primary pigmented nodular adrenocortical disease in Chinese adrenocorticotropic hormone-independent Cushing syndrome.

Authors:  Shi Chen; Ran Li; Lin Lu; Lian Duan; Xuebin Zhang; Anli Tong; Hui Pan; Huijuan Zhu; Zhaolin Lu
Journal:  Endocrine       Date:  2017-11-01       Impact factor: 3.633

7.  Case reports: old-timers and evergreens.

Authors:  C A Koch; T Fülöp
Journal:  J Med Case Rep       Date:  2018-11-27

Review 8.  Cushing's syndrome due to primary pigmented nodular adrenocortical disease--a case report reviews of the literature.

Authors:  K M Choi; J H Seu; Y H Kim; E J Lee; S J Kim; S H Baik; D S Choi
Journal:  Korean J Intern Med       Date:  1995-01       Impact factor: 2.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.